Table 3.
Characteristic | Total (n=163) | <1.0 cm growth (n=135) | ≥1.0 cm growth (n=26) | P value |
---|---|---|---|---|
Male sex – no. (%) | 97 (60) | 79 (59) | 16 (62) | 0.77 |
Age – yr (range) | 62 (27-86) | 63 (28-86) | 57 (27-86) | 0.09 |
Mode of discovery – no. (%) | ||||
Incidental | 140 (86) | 116 (86) | 23 (89) | 0.67 |
Cancer staging | 18 (11) | 15 (11) | 3 (11) | |
Mass effect symptoms | 5 (3) | 4 (3) | 0 (0) | |
Hemorrhage – no. (%) | 5 (3) | 1 (1) | 3 (12) | 0.007 |
Initial size (range) – cm | 2.4 (0.5-18.0) | 2.2 (0.5-13.3) | 3.6 (0.8-18.0) | 0.01 |
Adrenalectomy – no. (%) | 14 (9) | 5 (4) | 9 (35) | <.0001 |
Final size (range) – cm | 2.6 (0.5-19.3) | 2.3 (0.5-14.0) | 5.9 (2.3-19.3) | <.0001 |
Overall change in size (range) – mm | 0 (−10, 115) | 0 (−10, 95) | 20 (10-115) | <.0001 |
Rate of growth (range) – mm/yr | 0 (−6, 14) | 0 (−5.6, 14) | 3.0 (1-11.0) | <.0001 |